Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Humanigen Inc (NQ: HGEN ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Humanigen Inc < Previous 1 2 3 4 5 6 7 8 9 Next > The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In February 09, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Humanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France February 08, 2022 From Humanigen, Inc. Via Business Wire Humanigen Announces Peer-Reviewed Publication in The Journal of Medical Economics Demonstrating the Clinical and Economic Benefits of Lenzilumab January 18, 2022 From Humanigen, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Tuesday February 08, 2022 Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap... Via Benzinga Stocks That Hit 52-Week Lows On Friday February 04, 2022 On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... Via Benzinga 20 Stocks Moving in Monday's Pre-Market Session January 10, 2022 Gainers Bone Biologics Corporation (NASDAQ: BBLG) rose 32.1% to $4.53 in pre-market trading. Pluristem Therapeutics Inc. (NASDAQ: PSTI) rose 28.5% to $1.89 in pre-... Via Benzinga Humanigen Aligns with FDA on Potential Registration Phase 3 Study for Lenzilumab with CAR-T January 10, 2022 From Humanigen, Inc. Via Business Wire Humanigen Announces Target Enrollment in Phase 2/3 ACTIV-5/BET-B Trial of Lenzilumab for the Treatment of COVID-19 has Been Achieved January 05, 2022 From Humanigen, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Friday January 07, 2022 Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... Via Benzinga Humanigen to Present at Investor Conferences January 7 and 13, 2022 January 04, 2022 From Humanigen, Inc. Via Business Wire Lenzilumab Treatment Response in Hospitalized COVID-19 Patients Correlates with C-Reactive Protein Levels January 03, 2022 From Humanigen, Inc. Via Business Wire Humanigen Announces Presentation at 40th Annual J.P. Morgan Healthcare Conference in January 2022 December 15, 2021 From Humanigen, Inc. Via Business Wire Stocks Hitting New 52-Week Lows Today January 03, 2022 On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... Via Benzinga Humanigen, Inc. (NASDAQ:HGEN) Investor Notice: Investigation over Possible Wrongdoing December 13, 2021 San Diego, CA -- (SBWIRE) -- 12/13/2021 -- Certain directors of Humanigen, Inc are under investigation over potential breaches of fiduciary duties. Via SBWire Exposures COVID-19 Product Safety After FDA Rejection, Humanigen's COVID-19 Drug Hopeful Sees Some Light Of Good News December 02, 2021 Humanigen Inc (NASDAQ: HGEN) announced that The Lancet Respiratory Medicine published results from its LIVE-AIR Phase 3 trial of lenzilumab in hospitalized COVID-19... Via Benzinga Exposures COVID-19 Product Safety 65 Biggest Movers From Yesterday December 21, 2021 Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock... Via Benzinga 27 Stocks Moving in Thursday's Pre-Market Session December 02, 2021 Gainers Phunware, Inc. (NASDAQ: PHUN) rose 25.8% to $4.09 in pre-market trading after surging around 12% on Wednesday. Digital World Acquisition Corp. (NASDAQ: DWAC)... Via Benzinga Humanigen Announces Conference Call and Webcast to Discuss Lancet Respiratory Medicine Publications and Provide a Corporate Update December 01, 2021 From Humanigen, Inc. Via Business Wire The Lancet Respiratory Medicine Publishes Peer-Reviewed Paper and Independent Expert Commentary on Positive Phase 3 Lenzilumab Results December 01, 2021 From Humanigen, Inc. Via Business Wire These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19 November 29, 2021 Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... Via Benzinga 20 Stocks Moving in Monday's Pre-Market Session November 29, 2021 Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results... Via Benzinga Humanigen Announces Abstracts Accepted for the British Thoracic Society Winter Meeting 2021 November 22, 2021 From Humanigen, Inc. Via Business Wire Humanigen Announces Revised Time for Presentation at Jefferies London Healthcare Conference November 16, 2021 From Humanigen, Inc. Via Business Wire Humanigen Reports Third Quarter and Nine Months Ending September 30, 2021 Financial Results and Provides Corporate Update November 12, 2021 From Humanigen, Inc. Via Business Wire The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts November 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &... Via Benzinga Humanigen Announces Clinical Trial Collaboration to Evaluate Lenzilumab in Acute Graft Versus Host Disease November 11, 2021 From Humanigen, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session November 08, 2021 Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The company's market cap stands at $490.7 million. As per... Via Benzinga Humanigen Announces Release of Abstracts at ASH November 05, 2021 From Humanigen, Inc. Via Business Wire Humanigen Announces Participation and Presentation at Multiple Conferences in November November 02, 2021 From Humanigen, Inc. Via Business Wire European Commission Selects Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 October 26, 2021 From Humanigen, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
